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SUMMARY 
A complete cDNA encoding the acrosin-trypsin inhibitor, HUSI-II, was used as a probe to isolate genomic clones 
from a human placenta library. Three clones which cover the entire HUSI-ll gene were isolated and characterized. The 
exon-intron organization of the gene was determined and found to be identical to other known Kazal-type inhibitor-
encoding genes. The striking similarity in the amino acid sequences which was found previously in HUSI-II and 
glycoprotein hormone ß-subunits, is neither reflected in codon usage nor in the exon-intron arrangement of the genes. 
A 1.8-kb segment 5' of the gene was sequenced. The analysis of this sequence showed that HUSI-ll contains a G + C-
rich region upstream from the transcription start point (tsp) which fulfills the criteria for a CpG island. Furthermore, 
in the first intron, a potential glucocorticoid-responsive element was found as a half-palindrome flanked by two 
CACCC elements. Determination of the tsp by SI mapping revealed that HUSI-ll has multiple tsp. Genomic Southern 
hybridization was used to show that HUSI-ll is a single-copy gene. The localization of the gene to chromosome 4 was 
determined by hybridization of a 5' genomic fragment to the DNA of a panel of somatic hybrids between human and 
rodent cells. 
INTROOUCTION 
The acrosin-trypsin inhibitor HUSI-II isolated from 
human seminal plasma (Fink et al., 1971), seems to be 
synthesized exclusively in the male genital tract (Hehlein-
Fink, 1990). Its primary structure (Fink et al., 1990) iden-
tified it as a member of the Kazal-type inhibitor family 
(Laskowski and Kato, 1980). 
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* A compilation of regulatory and protein-interacting elements and a 
programme for localizing these regions is available on request from Or. 
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Kazal-type inhibitors, serine proteinase inhibitors, con-
tain one or more Kazal-type domains, which are protein 
domains with primary structures similar to that of the 
bovine pancreatic secretory trypsin inhibitor (Kazal et al., 
1948; Greene et al., 1969). Multiheaded Kazal-type inhibi-
tors contain up to seven domains, each having a distinct 
aa sequence and different inhibitory properties (Laskow-
ski and Kato, 1980). 
**Present address: Pharmacia Biosystems GmbH, Munzingerstraße 9, 
0-7800Freiburg/Br., Germany. Tel. (49-761)4903-294. 
Abbreviations: aa, amino acid(s); bp, base pair(s); cpm, counts/min; 
GRE, glucocorticoid-responsive element; hCGß, human chorionic 
gonadotropin, ß-subunit; HUSI-II, human seminal plasma inhibitor; 
HUSI-ll, gene encoding HUSI-II; kb, kilobase(s) or 1000 bp; nt, nucleo-
tide(s); oligo, oligodeoxyribonucleotide(s); PSTI, pancreatic secretory 
trypsin inhibitor; tsp, transcription start point(s). 
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To date, two human Kazal-type inhibitors have been 
isolated and characterized by aa sequencing. They are the 
PSTI (Greene et al., 1976), and the HUSI-II (Fink et al., 
1991). An oligo deduced from the aa sequence of HUSI-
II was employed to isolate and analyse cDNA-clones 
from testis and seminal vesicle libraries (Möritz et al. , 
1990). One of these cDNA clones was used to clone the 
HUSI-II gene in order to investigate the gene structure 
and regulation of expression of the inhibitor. 
EXPERIMENTAL AND DISCUSSION 
(a) Evidence that BUS/-li is a single-copy gene 
Genomic placenta DNA was digested with several re-
striction enzymes and a genomic Southern blot of the 
DNA was hybridized using a HUSI-II cD NA fragment 
(Möritz et al., 1991) as a probe (Fig. 1). The cDNA frag-
ment hybridized at high stringency to a maximum of 
three different restriction fragments of human placenta 
DNA. Such a low number of hybridizing fragments is 
generally taken as a strong indication that only a single 
copy of the gene occurs in the genome (Baumann et al., 
1988; Stühmer et al., 1989). 
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Fig. I. Genomic Southern blot analysis of the HUSI-1I gene. Genomic 
placenta DNA (10 ~g) was digested overnight at 37°C with: A, AccI; 
B, BamHI; E, EcoRI; H, HindIII; K, KpnI; P, PstI; S, SacI; X, Xbal. 
The digested DNA was resolved on a 0.8% agarose gel together with 
a DNA marker (kb on the left). Transfer onto a BiodyneA membrane 
(Pali, Dreieich, Germany), probing with a full-Iength HUSI-II cDNA 
fragment which was labeled by random priming using e2 p]dCTP, and 
washing of the membrane were performed as described by Sambrook 
et al. (1989). The sizes of the genomic EcoRI- and HindIII-fragments 
are as indicated on the right. They correspond to the genomic fragments 
iso la ted from digested genomic clones (Fig. 2). 
(b) Structure of the BUS/-li gene 
The gene structures of three Kazal-type inhibitors have 
been published: the two multiheaded inhibitors of 
chicken, ovomucoid with three domains (Stein et al., 
1980) and ovoinhibitor with seven domains (Scott et al., 
1987), and the human PSTI with one domain (Horii et al., 
1987; Tan et al., 1988). The exon-intron arrangement is 
identical in all these inhibitor genes (Tan et al., 1988): one 
intron is localized in the sequence encoding the leader 
peptide, 14 nt upstream from the N-terminus of the ma-
ture pro tein, and two introns are present within each of 
the eleven inhibitor domains: the first intron 10cated 6 nt 
upstream from the first Cys codon, the second intron 11 
nt downstream from the 5th Cys codon. 
Presuming an identical organisation of the HUSI-1I 
gene, the exon-intron structure was determined by using 
exonic oligos as primers for sequencing the exon-intron 
boundaries. The complete sequence of exons was con-
firmed by sequencing the complementary strand with in-
tron primers obtained from the new sequence data. 
Compared to the cDNA sequence (Möritz et al., 1991) 
one difference was detected: a C instead of the T 1169 
(Fig. 3) of the cDNA. This nt exchange represents a silent 
mutation of the codon of Val9 (Fig. 3) and probably re-
flects the fact that the genomic and cDNA libraries were 
obtained from specimens of different individuals. The 
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Fig.2. Restrietion map of the genomic region containing the HUS/-lI 
gene. 2 x 106 recombinant 2Dash phages (Stratagene, La Jolla, CA) from 
a genomic placental library were screened with full-Iength HUS/-lI 
cDNA (Möritz et al., 1991) as a probe ac'cording to Sambrook et al. 
(1989). Three hybridizing clones numbered 12, 15 and 16 were isolated. 
Full and partial digests of phage D N A of the three clones were prepared 
(Sambrook et al., 1989) to construct a restrietion map using the en-
zymes: EcoRI (E), BamHI (B), HindIll (H). Clone 12 was also digested 
with Acci (A), XbaI and PstI (P) to obtain shorter fragments for the 5' 
region sequence analysis; the resulting 1.8-kb AccI-PstI restriction frag-
ment used for sequencing (cf. Fig. 3) is boxed. The characterized region 
of about 30 kb is ftanked by artificial EcoRI cloning sites, E*, which 
originate from the 2Dash cloning vector. The three clones overlap as 
indicated be10w the map. Exon containing fragments were identified in 
hybridization experiments using oligos deduced from the cDNA se-
quence. No hybridization was observed for the 5' end EcoRI fragment 
(1.4 kb) and for the three EcoRI fragments (12.4 kb) representing the 3' 
part of the covered genomic region. Suitable fragments were subcloned 
into the vector pTZI9R (Mead et al., 1986) for further analysis. 
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Fig. 3. Organization and partial sequence of the HUSI-lI gene. Insert DNA of subclones was sequenced using the T7 Polymerase kit (Pharmacia 
Biosystems, Freiburg, Germany) with suitable primers (see section b). The 1.8-kb AccI-PstI fragment (containing l.l-kb 5' region, exon land 0.6 kb 
of intron I), exons 2, 3 and 4 including the exon-intron boundaries were sequenced. Genomic clones 12, 15 and 16 (Fig. 2) overlap in intron 2 as was 
deduced by sequence and mapping data. The start codon of the mature HUSI-II protein and the Cys codons, to which the intron positions are 
referred in section b, are marked by boldface, lowercase letters. Numbering of the nt sequence is arbitrary and corresponds only to the nt sequenced. 
The putative CpG island is italicized and marked by bold type, promoter elements are doubly underlined. rev, element located in the reverse orientation 
on the lower strand. The major tsp of the gene are marked by asterisks, the minor tsp is marked by a heavy dot. Only those restrietion sites of BstNI 
and TaqI are indicated which are important for SI mapping (see seetion e). The sequence data were analysed using the program Microgenie, version 
5 (Beckman Instruments). The sequence data have been deposited with the GenBank Data Library under accession Nos. M84967 and M91438. 
exon-intron arrangement ofthe HUS/-II gene is identical 
to that of the other published Kazal-type inhibitor genes 
and the same holds true for the intron phases: intron 1, 
phase 1; intron 2, phase 0; intron 3, phase 2. Furthermore, 
all introns obey the 5'GT ... AG3'-rule (Abe1son, 1979). 
(c) Comparison to the gene of human chorionic 
gonadotropin 
The aa seq uence of HUSI -11 shows a striking similarity 
to the ß-subunits of the glycoprotein hormones (Fink 
et al., 1990) which is most striking between aa 17 and 28 
(aa numbering of Fig. 3): 10 of the 12 aa are identical to 
a sequence of hCGß. In ß-chains of human luteinizing 
hormone, follicle-stimulating hormone and thyroid-
stimulating hormone the corresponding homology is only 
9, 6 and 5 aa, respectively. In Kazal-type proteinase inhib-
itors this segment includes the region of primary contact 
between the inhibitor and the proteinase and also the 
reactive inhibitor si te (Arg23_His24 in Fig. 3; discussed in 
detail by Laskowski, 1986). 
At the DNA level the sequence similarity is less pro-
nounced. In HUS/-II and hCGß (Policastro et al., 1983) 
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only 63% identity is observed for the corresponding nt 
sequences and only for 2 aa are the identical codons used. 
In addition, no similarity exists in the exon-intron orga-
nizations. This low similarity at the genomic level in con-
trast to the protein level suggests that after evolving from 
a common ancestor, the aa sequences have been con-
served in spite of the divergence because this segment is 
functionally important. It is tempting to speculate that, 
like in Kazal-type inhibitors (cf, above), the respective 
sequence segment in glycoprotein hormones will also be 
involved in complex formation, for example with either 
the hormone a-chain or the receptor. 
(d) Analysis of the 5' -flanking region of the BUS/-lI gene 
The search for regulatory elements in the 5' -flanking 
sequence (Fig. 3) showed that no TATA- or CCAAT-boxes 
are located upstream from the putative start codon of the 
HUSI-II protein. The 5' regions of TATA-less genes are 
often G + C rich and have been shown to contain the so-
called 'CpG islands' (Bird, 1986) which are thought to be 
involved in gene regulation (Weih et al., 1991). Indeed, a 
sequence segment fulfilling the criteria of a CpG island 
(Bird, 1986) is found between nt 781 and 1134 (Fig. 3): The 
G + C content of this region is 69% and the amount of the 
dinucleotides GpC and CpG is nearly identical (30: 28). 
CpG island genes often contain Sp I-motifs 
'GGGCGG' which are active in either direction (La-
Thangue and Rigby, 1988). In the BUS/-lI gene, five Spl 
boxes are found at nt 143, 973, 1023, 1035 and 1268; three 
of them are located within the CpG island. 
A half palindrome of the glucocorticoid-responsive ele-
ment 'GGTACAN3TGTTCT, to which androgen, pro-
gesterone and mineralocorticoid receptors can bind 
(Beato, 1989), is located at nt 1420 in the first intron of 
the BUS/-lI gene. It is flanked by two CACCC elements 
at nt 1358 and 1379 which act synergistically with gluco-
corticoid regulatory elements (Strähle et al., 1988). Half 
palindromic sequences of glucocorticoid elements can be 
functional (Tora et al., 1988) and can also be located in 
the first intron of genes (Strähle et al., 1988). 
Taken together, the analysis of the region upstream 
from the translation start point suggests a constitutive 
regulation of the BUS/-lI gene since it contains a CpG 
island with Spl-elements and no TATA- or CCAAT-
boxes (Dynan, 1986). In contrast, however, the analysis 
of 0.6 kb of intron 1 is consistent with the BUS/-lI gene 
being hormone-regulated as was indicated by previous 
experiments at the pro tein level (Haendle et al., 1965; 
Hehlein-Fink, 1990). 
(e) Transcription start points (tsp) ofthe BUS/-lI gene 
If a TATA-box is absent or deleted experimentally, 
multiple tsp are often found (Reynolds et al., 1984). SI 
analysis of the TATA-less BUS/-lI gene confirms this 
finding: one minor and four major tsp at nt 1048, 1060, 
1062, 1072 and 1096 (nt numbering of Fig. 3) were de-
tected (Fig. 4). Furthermore, the tsp at nt 1060 corres-
ponds to the start of the full-length cDNA clone used for 
isolating the BUS/-lI gene (Fig. 3). 
(f) Chromosomal assignment of the BUS/-lI gene 
A 551-bp SacI-KpnI-fragment (nt 738-1288, Fig.3), 
which contains no repetitive sequences and, therefore, hy-
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Fig.4. SI map of the HUSI-Il gene. The 1.8-kb AccI-PstI-fragment 
containing the 5' region of the HUSI-I I gene (Fig. 3) was digested with 
BstNI. The resulting 8l2-bp BstNI fragment (nt 350-1161, Fig. 3) was 
dephosphorylated (Sambrook et al., 1989) and further digested with 
TaqI yielding a 5l7-bp TaqI-BstNI fragment(nt 644-1161, Fig. 3) which 
is dephosphorylated only at the BstNI si te in exon I (nt 1461, Fig.3). 
It was separated from the 299-bp BstNI-TaqI fragment (nt 350-643, 
Fig.3) and labeled with [y_ 32 p]ATP (5000 Ci/mmol, Amersham, 
Braunschweig; Sambrook et al., 1989). For hybridization, 50000 cpm 
of the fragment nt 644-1161 (Fig. 3) and 20 Jlg total testis RNA (lane 
1) or 2 Jlg poly(A)+ testis RNA (lane 2) were coprecipitated with ethanol. 
The quality of RNAs was confirmed by Northern analysis prior to SI 
mapping. DNA and RNA were resuspended in 20 JlI hybridization 
buffer (40 mM PIPES-KOH pH 6.4/400 mM NaCljI mM EDTA/80% 
formamide). After 30 min at 8SOC, the sampIes were incubated at 52°C 
for 8-12 h submersed in a water bath. SI digestion of single-stranded 
nucleic acids was performed (Sambrook et al., 1989) and, after phenol 
extraction, the protected fragments were separated on a 6% sequencing 
gel and visualized by autoradiography. A sequencing ladder was in-
cluded to enable accurate determination of the product sizes (Ianes A, 
G, C and T; these are overexposed because the sequencing reaction was 
not optimal). The four major tsp are marked by asterisks, the minor tsp 
is marked by a heavy dot. The numbering on the right refers to the 
lengths of protected fragments found by this analysis. 
bridizes only with the 9.1-kb genomic EcoRI-fragment of 
the HUSI-II gene, was used to probe a Southern blot of 
EcoRI-restricted genomic DNA from a panel of human-
rodent hybrid cell lines (Luerssen et al., 1990). The frag-
ment segregated with chromosome 4. In one clone, which 
cytogenetically shows no intact chromosome 4, it segre-
gated with a marker known to be localized close to the 
tip of the short arm of chromosome 4, but not with a 
marker previously assigned to the long arm. This might 
indicate that the HUSI-II gene is located on 4p. 
ACKNOWLEDGMENTS 
We thank Dr. H. Gram, Sandoz Pharma Ltd., Basel, 
Switzerland for providing the placenta library and Dr. 
F. Tan, University of Illinois, Chicago, IL for providing 
genomic placenta DNA. This work was supported by the 
Sonderforschungsbereich 207 of the University of Mu-
nich and grant Gr 373/16-2. 
REFERENCES 
Abelson, J.: RNA processing and the intervening sequence problem. 
Annu. Rev. Bioehern. 48 (1979) 1035-1069. 
Baumann, A., Grupe, A., Ackermann, A. and Pongs, 0.: Structure of 
the voltage-dependent potassium channel is highly conserved from 
Drosophila to vertebrate central nervous system. EMBO J. 7 (1988) 
2457-2453. 
Beato, M.: Gene regulation by steroid hormones. CelJ 56 (1989) 
335-344. 
Bird, A.P.: CpG rich islands and the function of DNA methylation. 
Nature 321 (1986) 209-213. 
Dynan, W.S.: Promoters for housekeeping genes. Trends Genet. 2 (1986) 
196-197. 
Fink, E., Jaumann, E., Fritz, H., Ingrisch, H. and Werle, E.: Protease-
Inhibitoren im menschlichen Spermaplasma: Isolierung durch 
Affinitätschromatographie und Hemmverhalten. Hoppe-Seyler's Z. 
Physiol. Chem. 352 (1971) 1591-1594. 
Fink, E., Hehlein-Fink, C. and Eulitz, M.: Amino acid sequence elucida-
ti on of human acrosin-trypsin inhibitor (HUSI-II) reveals that Kaz-
al-type proteinase inhibitors are structuralJy related to beta-subunits 
of glycoprotein hormones. FEBS Lett. 270 (1990) 222-224. 
Greene, L.I. and Bartelt, D.C.: The structure of the bovine pancreatic 
secretory trypsin inhibitor - Kazal's inhibitor. 11 The order of the 
tryptic peptides. J. Biol. Chem. 244 (1969) 2646-2657. 
Greene, L.J., Pubols, M.H. and Bartelt, D.C.: Human pancreatic secre-
tory trypsin inhibitor. Methods Enzymol. 45 (1976) 813-825. 
Haendle, H., Fritz, H., Trautschold, Land Werle, E.: Über einen 
hormonabhängigen Inhibitor für proteolytische Enzyme in 
männlichen accessorischen Geschlechtsdrüsen und im Sperma. 
Hoppe Seyler's Z. Physiol. Chem. 343 (1965) 185-188. 
Hehlein-Fink, c.: Aufklärung der Primärstruktur des humanen 
Akrosininhibitors HUSI-II und Untersuchungen zu seiner physio-
logischen Funktion. Thesis, Technical University Munieh, 1990. 
281 
Horii, A., Kobayashi, T., Tomita, N., Yamamoto, T., Fukushige, S., 
Murotsu, T., Ogawa, M., Mori, T. and Matsubara, K.: Primary 
structure of the human pancreatic secretory trypsin inhibitor (PSTI) 
gene. Bioehern. Biophys. Res. Commun. 149 (1987) 635-641. 
Kazal, L.A., Spicer, D.S. and Brahinski, R.A.: Isolation of a crystalline 
trypsin inhibitor-anticoagulant protein from pancreas. J. Am. Chem. 
Soc. 70 (1948) 3034-3040. 
Laskowski Jr., M.: Protein inhibitors of serine proteinases - mechanism 
and classification. In: M. Friedman (Ed.), Nutritional and Toxico-
logical Significance of Enzyme Inhibitors in Foods. Plenum, New 
York, 1986, pp. 1-17. 
Laskowski Jr., M. and Kato, I.: Protein inhibitors ofproteinases. Annu. 
Rev. Bioehern. 49 (1980) 593-626. 
LaThangue, N.ß. and Rigby, P.WJ.: Trans-acting protein factors and 
the regulation of eukaryotic transcription. In: Harnes, B.D. and 
Glover, D.M. (Eds.), Transcription and Splicing. IRL Press, Oxford, 
1988, pp. 1-42. 
Luerssen, H., Mattei, M.-G., Schröter, M., Grzeschik, K.-H., Adham, 
I.M. and Engel, W.: Nucleotide sequence of the gene for human 
transition protein land its chromosomal localization on chromo-
some 2. Genomics 8 (1990) 324-330. 
Mead, D.A., Szczesna-Skorupa, E. and Kemper, B.: Single-stranded 
DNA 'blue' T7 promoter plasmids: a versatile tandem promoter 
system for cloning and protein engineering. Prot. Eng. I (1986) 
67-74. 
Möritz, A., Lilja, H. and Fink, E.: Molecular cloning and sequence 
analysis of the cDNA encoding the human acrosin-trypsin inhibitor 
(HUSI-II). FEBS Lett. 278 (1991) 127-130. 
Policastro, P., Ovitt, C.E., Hoshina, M., Fukuoka, H., Boothby, M.R. 
and Boime, I.: The ß-subunit of human chorionic gonadotropin is 
encoded by multiple genes. J. Biol. Chem. 258 (1983) 11492-11499. 
Reynolds, GA, Basu, S.K., Osborne, T.F., Chin, DJ., Gil, G., Brown, 
M.S., Goldstein, 1.L. and Luskey, K.L.: HMG CoA reductase: a 
negatively regulated gene with unusual promoter and 5' un-
translated region. CelJ 38 (1984) 275-285. 
Sambrook, J., Fritsch, E.F. and Maniatis, T.: Molecular Cloning. A 
Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, 
Cold Spring Harbor, NY, 1989. 
Scott, MJ., Huckaby, C.S., Kato, 1., Kohr, WJ., Laskowski Jr., M., 
Tsai, M.-J. and O'MalJey, B.W.: Ovoinhibitor introns specify func-
tional domains as in the related and Iinked ovomucoid gene. 1. Biol. 
Chem. 262 (1987) 5899-5907. 
Stein, J.P., CatteralJ, J.F., Kristo, P., Means, A.R. and O'MalJey, ß.W.: 
Ovomucoid intervening sequences specify functional domains and 
genera te protein polymorphism. CelJ 21 (1980) 681-687. 
Strähle, U., Schmid, W. and Schütz, G.: Synergistic action of the gluco-
corticoid receptor with transcription factors. EMBO J. 7 (1988) 
3389-3395. 
Stühmer, W., Ruppersberg, J.P., Schröter, K.H., Sakmann, B., Stock-
er, M., Giese, K.P., Perschke, A. and Pongs, 0.: Molecular basis of 
functional diversity ofvoltage-gated potassium channels in mamma-
lian brain. EMBO I. 8 (1989) 3235-3244. 
Tan, F., Gippner, C. and Fink, E.: On the genomic organization of the 
human pancreatic secretory trypsin inhibitor gene. Biol. Chem. 
Hoppe Seyler's 369, Suppl. 5 (1988) 51-54. 
Tora, L., Gaub, M.P., Mader, S., Dierich, A., BelJard, M. and Cham-
bon, P.: CelJ-specific activity of a GGTCA half-palindromic oestro-
gen-responsive element in the chicken ovalbumin gene promoter. 
EMBO J. 7 (1988) 3771-3778. 
Weih, F., Nitsch, D., Reik, A., Schütz, G. and Becker, P.ß.: Analysis of 
CpG methylation and genomic footprinting at the tyrosine amino-
transferase gene: DNA methylation alone is not sufficient to prevent 
protein binding in vivo. EMBO J. 10 (1991) 2559-2567. 
